VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,655,000 | +24.4% | 166,780 | +62.3% | 0.11% | +13.8% |
| Q4 2017 | $2,135,000 | +113.5% | 102,780 | +13.3% | 0.09% | +104.3% |
| Q1 2017 | $1,000,000 | -16.4% | 90,700 | +10.1% | 0.05% | -35.2% |
| Q4 2016 | $1,196,000 | -22.6% | 82,400 | +958.3% | 0.07% | +34.0% |
| Q1 2015 | $1,546,000 | -31.9% | 7,786 | -54.8% | 0.05% | -55.8% |
| Q1 2014 | $2,270,000 | -58.8% | 17,223 | -63.3% | 0.12% | -59.0% |
| Q4 2013 | $5,507,000 | – | 46,911 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |